Bioptimus
8 known investors
Bioptimus builds multimodal foundation models for biology, including H-Optimus for histology and M-Optimus which integrates pathology, spatial transcriptomics, and genomics, to extract clinically relevant insights from patient data. Its models serve pharmaceutical companies, researchers, and clinical practices for applications such as drug target prediction, patient stratification in trials, and biomarker discovery.
AI & Machine LearningBiotechDigital Health
Investors · 8
Founder mafia
2 people who came through Bioptimus went on to found or lead other companies.
In the news
Frequently asked questions
- What does Bioptimus do?
- Bioptimus builds multimodal foundation models for biology, including H-Optimus for histology and M-Optimus which integrates pathology, spatial transcriptomics, and genomics, to extract clinically relevant insights from patient data. Its models serve pharmaceutical companies, researchers, and clinical practices for applications such as drug target prediction, patient stratification in trials, and biomarker discovery.
- Who are Bioptimus's investors?
- Bioptimus's investors include Andera Partners, Cathay Innovation, FELIX CAPITAL, Headline, Headline Growth Management, LLC, Hitachi Ventures, Sofinnova Partners, Frst.